Rapport Catapults Almost 200% After Succeeding In Hard-To-Treat SeizuresInvestors Business Daily • 09/08/25
Rapport Announces Positive Topline Results from Phase 2a Clinical Trial of RAP-219 in Patients with Focal Onset SeizuresGlobeNewsWire • 09/08/25
Rapport Therapeutics to Announce Topline Results for RAP-219 Phase 2a Trial in Focal Onset Seizures on Monday, September 8, 2025GlobeNewsWire • 09/05/25
Rapport Therapeutics Reports Second Quarter 2025 Financials and Provides Business UpdateGlobeNewsWire • 08/07/25
Rapport Therapeutics Hosts Investor and Analyst Day; Provides Corporate UpdatesGlobeNewsWire • 06/02/25
Rapport Therapeutics to Participate in the Jefferies Global Healthcare Conference and Goldman Sachs 46th Annual Global Healthcare ConferenceGlobeNewsWire • 05/27/25
Rapport Therapeutics Reports First Quarter 2025 Financials and Provides Business UpdateGlobeNewsWire • 05/08/25
Crédit Agricole Ille-et-Vilaine : Communiqué de mise à disposition du rapport financier 2024GlobeNewsWire • 03/27/25
Bpce: Mise à disposition du document d'enregistrement universel 2024 et du rapport financier annuel du Groupe BPCEGlobeNewsWire • 03/21/25
Rapport Therapeutics to Present Data at the 2025 American Academy of Neurology Annual MeetingGlobeNewsWire • 03/21/25
Correction: Mise à disposition des éléments préparatoires à l'AG du 28/03/2025 - Rapport Financier Annuel 2024GlobeNewsWire • 03/13/25
Mise à disposition des éléments préparatoires à l'AG du 28/03/2025 - Rapport Financier Annuel 2024GlobeNewsWire • 03/13/25
Rapport Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business UpdateGlobeNewsWire • 03/11/25
Rapport Therapeutics Announces Appointment of Dr. Jeffrey Sevigny as Chief Medical Officer to Drive Clinical Strategy and Precision Medicine DevelopmentGlobeNewsWire • 03/03/25
CORRECTION -- Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS DisordersGlobeNewsWire • 01/09/25
Rapport Therapeutics Announces New Phase 1 Data, Further Supporting RAP-219's Transformative Potential for CNS DisordersGlobeNewsWire • 01/09/25
Rapport Therapeutics Presents Data Demonstrating Consistent Association Between Decreases in RNS Measured Long Episodes and Meaningful Reductions in Clinical SeizuresGlobeNewsWire • 12/06/24